HealthCare Global Enterprises Limited

BSE: HCG539787ISIN INE075I01017

Healthcare
Hospital
BSE 1000

Share price

₹621.95+16.55 (+2.73%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded. Earlier history is omitted pending corporate-action verification.

52W high: —
52W low: —
Off 52W high: —
1M return: -7.00%
3M return: -7.08%
6M return: +0.22%
1Y return: —
20D avg volume: 22,923
50 DMA: ₹654.24
200 DMA: —

Key ratios Consolidated

Market cap: ₹9,286 Cr
Current price: ₹621.95
52W high / low: — / —
Face value: ₹10.00
P/E: 279.19
P/B: 6.97
EPS (TTM): ₹2.23
Book value / share: ₹89.21
ROE: —
ROCE: 6.90%
Operating margin: —
Net margin: —
Debt / equity: 0.65
Net debt: ₹374.36 Cr
Interest cover: 1.14
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 18.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	695.10	652.33	633.07	646.85	613.16	585.16	557.55	553.54	525.58	494.63	469.87	486.94
	12.13	13.07	2.47	2.62	6.83	10.23	5.66	11.13	8.81	5.05	6.07	3.40
	707.23	665.40	635.54	649.47	619.99	595.39	563.21	564.67	534.39	499.68	475.94	490.34
	683.13	632.76	628.89	629.96	608.75	581.68	567.41	536.99	515.39	475.42	464.87	472.41
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	186.84	180.70	173.43	181.22	166.33	154.08	151.76	148.64	135.74	124.65	112.59	122.09
	104.52	92.47	94.18	94.18	97.77	92.81	90.24	85.27	85.16	76.85	77.33	77.16
	39.87	42.70	44.78	43.62	45.47	44.17	40.70	35.98	33.71	26.84	29.46	26.89
	70.42	62.81	60.65	62.80	57.91	58.07	56.52	49.74	47.01	45.98	44.16	43.21
	289.52	258.07	252.71	252.21	245.73	232.60	108.31	103.88	104.23	97.41	95.70	98.01
	24.10	32.64	6.65	19.51	11.24	13.71	-4.20	27.68	19.00	24.26	11.07	17.93
	0.00	-31.91	-12.67	0.00	0.00	0.00	0.00	0.00	0.00	3.90	0.00	0.00
	24.10	0.73	-6.02	19.51	11.24	13.71	-4.20	27.68	19.00	28.16	11.07	17.93
	8.57	2.79	1.83	0.84	5.94	6.85	11.05	6.97	5.36	4.76	7.63	7.14
	16.46	4.04	-7.90	20.66	5.98	6.77	7.75	20.68	13.63	23.46	3.43	10.78
	0.92	0.15	-0.68	1.16	0.34	0.53	0.50	1.29	0.87	1.53	0.41	0.97
Key metrics
	134.39	106.24	99.41	125.93	114.62	115.95	93.02	113.40	99.72	100.98	84.69	88.03
	19.30%	16.30%	15.70%	19.50%	18.70%	19.80%	16.70%	20.50%	19.00%	20.40%	18.00%	18.10%
	2.40%	0.60%	-1.20%	3.20%	1.00%	1.20%	1.40%	3.70%	2.60%	4.70%	0.70%	2.20%
	—	1.50%	—	2.50%	—	2.30%	—	—	—	—	—	—
	13.40%	11.50%	13.50%	16.90%	16.70%	18.30%	18.70%	13.70%	—	—	—	—
	175.30%	-40.30%	-201.90%	-0.10%	-56.10%	-71.10%	125.90%	91.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	2,627	2,545	2,223	1,912	1,694	1,398
	30.29	24.99	34.81	16.94	13.18	12.67
	2,658	2,570	2,258	1,929	1,708	1,410
	2,575	2,500	2,201	1,866	1,663	1,416
	0.00	0.00	0.00	—	—	—
	722.19	701.68	590.22	479.37	432.38	360.97
	385.35	378.60	353.48	308.24	275.12	233.65
	170.97	176.57	154.56	108.74	103.50	97.77
	256.68	244.17	211.34	174.36	163.47	158.28
	1,053	1,009	901.49	385.30	340.46	275.44
	82.90	70.04	56.19	63.43	44.89	-5.40
	-44.58	-44.58	0.00	3.90	0.00	94.61
	38.32	25.46	56.19	67.33	44.89	89.21
	14.03	4.14	8.13	26.40	27.25	48.85
	33.26	22.78	48.83	41.32	17.62	38.92
	1.55	0.97	3.19	3.46	2.11	4.14
Key metrics
	465.97	446.20	422.09	350.43	311.86	345.26
	17.74%	17.50%	19.00%	18.30%	18.40%	24.70%
	1.27%	0.90%	2.20%	2.20%	1.00%	2.80%
	—	6.90%	8.40%	—	—	—
	13.77%	14.50%	16.30%	12.80%	21.20%	—
	-19.23%	-53.30%	18.20%	134.50%	-54.70%	—
	—	55.00	108.25	—	—	—
	—	15.24	6.49	—	—	—
	—	0.65	1.01	—	—	—
	—	374.36	766.36	—	—	—
	—	18.6	19.6	—	—	—
Balance sheet
	—	3,923	3,543	—	—	—
	—	1,068	843.80	—	—	—
	—	536.05	235.87	—	—	—
	—	420.70	400.90	—	—	—
	—	59.82	53.02	—	—	—
	—	32.41	34.50	—	—	—
	—	2,041	1,963	—	—	—
	—	351.04	334.26	—	—	—
	—	982.72	1,046	—	—	—
	—	910.41	1,002	—	—	—
	—	311.22	397.65	—	—	—
	—	599.19	604.58	—	—	—
	—	1,410	990.05	—	—	—
Cash flow
	—	347.10	317.12	—	—	—
	—	-177.47	-487.75	—	—	—
	—	240.67	-42.44	—	—	—
	—	292.10	208.87	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	376.66	350.21	342.16	345.84	327.09	324.39	311.67	306.67	293.61	280.38	267.21	282.75
	9.56	14.92	2.99	3.82	7.94	9.46	6.13	10.24	10.50	4.12	5.52	2.13
	386.22	365.13	345.15	349.66	335.03	333.85	317.80	316.91	304.11	284.50	272.73	284.88
	378.74	326.56	338.56	335.06	329.79	317.04	319.36	295.92	288.90	264.81	257.78	266.60
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	95.61	95.13	88.50	90.77	84.24	78.75	81.78	73.46	67.61	60.19	54.51	62.55
	59.67	50.78	51.87	52.86	56.41	52.11	56.02	53.74	54.15	48.91	50.04	49.42
	21.73	20.19	20.61	21.36	24.30	22.50	21.27	20.16	19.34	14.09	13.21	10.98
	39.57	31.30	30.09	30.16	28.25	29.05	27.90	27.13	25.84	25.19	24.09	23.28
	165.76	132.24	144.88	141.31	140.20	133.92	71.00	63.54	65.75	62.41	60.99	64.93
	7.48	38.57	6.59	14.60	5.24	16.81	-1.56	20.99	15.21	19.69	14.95	18.28
	0.00	-47.52	-7.86	0.00	0.00	0.00	-34.82	—	—	-16.10	—	—
	7.48	-8.95	-1.27	14.60	5.24	16.81	-36.38	20.99	15.21	3.59	14.95	18.28
	1.90	-10.48	-0.09	3.82	1.79	6.65	0.95	4.96	3.49	5.35	6.62	4.58
	5.58	1.53	-1.18	10.78	3.45	10.16	-37.33	16.03	11.72	-1.76	8.33	13.70
	0.37	0.11	-0.08	0.77	0.25	0.73	-2.68	1.15	0.84	-0.13	0.60	0.98
Key metrics
	68.78	42.54	49.43	66.12	57.79	68.36	12.79	68.28	60.39	42.87	52.25	52.54
	18.30%	12.10%	14.40%	19.10%	17.70%	21.10%	4.10%	22.30%	20.60%	15.30%	19.60%	18.60%
	1.50%	0.40%	-0.30%	3.10%	1.10%	3.10%	-12.00%	5.20%	4.00%	-0.60%	3.10%	4.80%
	—	0.50%	—	1.80%	—	2.00%	—	—	—	—	—	—
	15.20%	8.00%	9.80%	12.80%	11.40%	15.70%	16.60%	8.50%	—	—	—	—
	61.70%	-84.90%	96.80%	-32.80%	-70.60%	677.30%	-548.10%	17.00%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,415	1,365	1,280	1,103	1,008	851.96
	31.29	29.67	34.61	13.60	8.80	10.29
	1,446	1,395	1,315	1,116	1,016	862.25
	1,379	1,330	1,261	1,045	955.77	834.12
	0.00	0.00	0.00	—	—	—
	370.01	358.64	321.25	245.08	240.20	213.26
	215.18	211.92	220.58	197.15	175.03	156.63
	83.89	86.46	84.14	47.97	41.49	42.80
	131.12	119.80	111.39	94.20	88.97	88.36
	584.19	558.63	526.94	247.26	219.79	175.28
	67.24	65.00	54.40	70.96	60.62	28.13
	-55.38	-55.38	-34.82	-16.10	-3.00	52.91
	11.86	9.62	19.58	54.86	57.62	81.04
	-4.85	4.96	16.05	20.90	17.43	42.79
	16.71	14.58	3.53	33.96	40.19	38.25
	1.17	1.03	0.25	2.44	2.89	2.95
Key metrics
	226.87	215.88	215.11	197.03	188.08	212.20
	16.03%	15.80%	16.80%	17.90%	18.70%	24.90%
	1.18%	1.10%	0.30%	3.10%	4.00%	4.50%
	—	4.00%	5.20%	—	—	—
	11.42%	6.60%	16.10%	9.40%	18.30%	—
	—	313.00%	-89.60%	-15.50%	5.10%	—
	—	6.02	13.23	—	—	—
	—	10.99	41.35	—	—	—
	—	0.35	0.55	—	—	—
	—	92.94	493.26	—	—	—
	—	33.4	36.9	—	—	—
Balance sheet
	—	2,917	2,604	—	—	—
	—	849.37	640.45	—	—	—
	—	474.11	158.03	—	—	—
	—	262.15	261.98	—	—	—
	—	25.24	19.76	—	—	—
	—	25.10	26.97	—	—	—
	—	1,025	935.02	—	—	—
	—	162.22	152.16	—	—	—
	—	530.41	622.84	—	—	—
	—	567.05	651.29	—	—	—
	—	251.99	347.72	—	—	—
	—	315.06	303.57	—	—	—
	—	1,605	1,191	—	—	—
Cash flow
	—	160.19	145.95	—	—	—
	—	-75.81	-347.33	—	—	—
	—	336.21	-41.55	—	—	—
	—	154.17	132.72	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +10.66%
Sales CAGR 5Y: —
Profit CAGR 3Y: -28.68%
Profit CAGR 5Y: —
Sales YoY (TTM): +11.42%
Profit YoY (TTM): +317.30%

Consolidated

Sales CAGR 3Y: +14.53%
Sales CAGR 5Y: —
Profit CAGR 3Y: +8.94%
Profit CAGR 5Y: —
Sales YoY (TTM): +13.77%
Profit YoY (TTM): -19.23%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 64.21%

Quarter	September 2026	June 2026
Promoter %	64.21%	64.21%

Holder	Type	Holding	Previous	Change
HECTOR ASIA HOLDINGS II PTE. LTD.	Promoter	54.27%	54.27%	0.00%
B S AJAIKUMAR	Promoter	9.30%	9.30%	0.00%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA ELS	Public	5.88%	5.88%	0.00%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND	Public	4.27%	3.58%	+0.69%
TATA MUTUAL FUND - TATA ELSS -TAX SAVER FUND	Public	4.13%	—	—
FRANKLIN INDIA SMALL CAP FUND	Public	1.57%	—	—
SBI HEALTHCARE OPPORTUNITIES FUND	Public	1.00%	—	—
ASMITHA AJAIKUMAR	Promoter Group	0.23%	0.23%	0.00%
AAGNIKA AJAIKUMAR	Promoter Group	0.23%	0.23%	0.00%
CATALYST TRUSTEESHIP LIMITED	Promoter	0.18%	0.18%	0.00%
ANJALI AJAIKUMAR ROSSI	Promoter Group	0.00%	0.00%	0.00%
BHAGYA A AJAIKUMAR	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Newspaper Advertisement in respect of Special Window for transfer and dematerialisation of Physical Securities of the Company.29 Oct 2026 · Company Update / Newspaper Publication
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, of the Company for the quarter ended September 30, 2026.15 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Further to our intimation made on October 13, 2026, regarding the meeting of the Board of Directors of the Company scheduled to be held on Thursday, November 05, 2026, inter alia, to consider, ....13 Oct 2026 · Company Update / Analyst / Investor Meet
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve inter-alia the ....13 Oct 2026 · Board Meeting / Board Meeting
Pursuant to Regulation 30 of SEBI Listing Regulations, we would like to inform you that Healthcare Global (Kenya) Private Limited, a step-down subsidiary of the Company has today, i.e., ....5 Oct 2026 · Company Update / Acquisition
Intimation regarding closure of Trading Window of the Company for the quarter and half year ending September 30, 2026.30 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Scrutinizer''s Report and Voting Results for the agenda(s) listed in the Notice of 28th Annual General Meeting of the Company.18 Sep 2026 · AGM/EGM / AGM
Intimation regarding summary of proceedings of 28th Annual General Meeting of the Company.18 Sep 2026 · AGM/EGM / AGM
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure requirements), Regulations 201517 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of Schedule of meetings with Institutional Investors at Mumbai.16 Sep 2026 · Company Update / Analyst / Investor Meet
The Nomination and Remuneration Committee of the Board of Directors of the Company, at its meeting held today, i.e., September 09, 2026, has approved grant of Employee Stock Options to ....9 Sep 2026 · Company Update / General
Please note that letters are being dispatched to the Members of the Company containing web link and path of Integrated Annual Report for Financial Year 2025-26.28 Aug 2026 · Company Update / General
Newspaper advertisement pertaining to dispatch of 28th Annual General Meeting and Integrated Annual Report for FY 2025-26.28 Aug 2026 · Company Update / Newspaper Publication
Please find enclosed the Notice of 28th Annual General Meeting and Integrated Annual Report of the Company for FY 2025-26.27 Aug 2026 · AGM/EGM / AGM
Please find enclosed the Integrated Annual Report of the Company for FY 2025-26.27 Aug 2026 · Others / Reg. 34 (1) Annual Report
Please find enclosed the Business Responsibility and Sustainability Report ("BRSR") of the Company for FY 2026.27 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Newspaper advertisement pertaining to Notice of Annual General Meeting in accordance with MCA General Circular No. 20/2020 dated May 05, 2020.25 Aug 2026 · Company Update / Newspaper Publication
Please find attached herewith the Transcript of Earnings Call held on August 07, 2026, with Analysts/Investors to discuss the Unaudited Financial Results (Standalone and Consolidated) of ....10 Aug 2026 · Company Update / Earnings Call Transcript
Newspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, approved at the meeting of Board of Directors held ....8 Aug 2026 · Company Update / Newspaper Publication
This is to inform that the Company will be participating in the group investor meeting hosted by Ambit Capital in Bangalore.7 Aug 2026 · Company Update / Analyst / Investor Meet
This is to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on August 07, 2026, to discuss the Unaudited Financial Results (Standalone and Consolidated) ....7 Aug 2026 · Company Update / Analyst / Investor Meet
Press release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.6 Aug 2026 · Company Update / Press Release / Media Release
Investor Presentation on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.6 Aug 2026 · Company Update / Investor Presentation
Monitoring Agency Report for the quarter ended June 30, 2026, in relation to the Rights Issue of the Company..6 Aug 2026 · Company Update / Monitoring Agency Report
Statement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June 30, 2026.6 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
The Board of Directors has approved the re-appointment of M/s Rao Murthy & Associates, Cost Accountants as Cost Auditors of the Company for the financial year 2026-27.6 Aug 2026 · Company Update / Change in Management
The Board of Directors of the Company has approved a further investment of up to INR 16 Crores in HCG Rajkot Hospitals LLP, a wholly-owned subsidiary of the Company.6 Aug 2026 · Company Update / Acquisition
Unaudited Financial Results of the Company for the quarter ended June 30, 2026.6 Aug 2026 · Result / Financial Results
The Company has announced the Outcome of the Board meeting held on August 06, 2026, including approval of unaudited financial results of the Company for the quarter ended June 30, 2026.6 Aug 2026 · Board Meeting / Outcome of Board Meeting
Pursuant to Regulation 30 of LODR, we would like to inform that HCG Manavata Oncology LLP, a subsidiary LLP, of the Company has entered into agreement to acquire 26% equity stake in Epic ....4 Aug 2026 · Company Update / Acquisition
Further to the intimation submitted to Stock Exchanges dated July 27, 2026, with respect to the meeting of the Board of Directors of the Company, to be held on Thursday, August 06, 2026, ....27 Jul 2026 · Company Update / Analyst / Investor Meet
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the Unaudited ....27 Jul 2026 · Board Meeting / Board Meeting
Newspaper Advertisement in respect of Special Window for Transfer and Dematerialisation of Physical Securities of the Company.25 Jul 2026 · Company Update / Newspaper Publication
Scrutinizers report and Outcome of the Postal Ballot for the agenda(s) listed in the Postal Ballot Notice dated June 08, 2026, of the Company.9 Jul 2026 · AGM/EGM / Postal Ballot
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.3 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation for closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015, for the quarter ending June 30, 2026.30 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation regarding completion of divestment by the Company of its entire shareholding in BACC Health Care Private Limited, subsidiary of the Company, pursuant to the Share Purchase Agreement ....29 Jun 2026 · Company Update / Diversification / Disinvestment
The Directorate General of Health Services, Central Drugs Standard Control Organization (Ethics Committee Division) has issued an order dated June 12, 2026, (received on June 16, 2026) ....17 Jun 2026 · Company Update / General
Newspaper Advertisement in respect of Special Window for Transfer and Dematerialisation of Physical Securities of the Company.13 Jun 2026 · Company Update / Newspaper Publication
Newspaper advertisement of Postal Ballot Notice dated June 08, 2026, of the Company.9 Jun 2026 · Company Update / Newspaper Publication

Corporate actions

Purpose	Ex date	Record date	Payment date
Right Issue of Equity Shares	2 Mar 2026	2 Mar 2026	—

Board meetings

5 Nov 2026 Board Meeting - Financial Results
6 Aug 2026 Board Meeting - Financial Results